CSL Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. The company's therapeutic areas includes Immunoglobulins, Immunology, Immunology Haematology, Cardiovascular and Renal, and Vaccines. It also licenses CSL intellectual property. It also develops vaccines for the prevention of infectious disease. The company has strategic collaboration with Dutch biotech company VarmX BV for the development of VMX-C001 to help restore blood coagulation in patients requiring urgent surgery. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Key Metrics
PE ratio
-
PB ratio
4.09
Dividend yield
2.28%
Beta
0.13
Market cap
$85.21B
Enterprise value
$95.93B
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Full time employees | 29000 |
| Website | https://www.csl.com |
| Mailing address | 655 Elizabeth Street Melbourne VIC 3000 Australia |
| Phone / Fax | 61 3 9389 1911 / 61 3 9389 1434 |
Dividends
More: CSL Dividend history, yield and payout ratio
Dividend yield
2.28%
Dividend amount
$4.05
Payout ratio
45.49%
5Y Avg. yield
-%
CSL paid $4.05 dividend and the ex-dividend date was 09 Sep 2026.The dividend payout ratio is 45.49%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CSL dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Sep 2026, following are the company executives and directors listed on CSL.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Ken Lim | Chief Financial Officer | 51 | |
| Dr. Mary Oates Ph.D. | Executive VP & COO | 62 | |
| Michelle Rees | Head of Investor Relations | ||
| Mr. Gregory Boss B.S., BS(Hons), J.D. | Executive VP of Legal & Group General Counsel | 64 | |
| Ms. Amy Van Buren | Chief People Officer | 50 | |
| Dr. William Mezzanotte M.D., M.P.H. | Chief Medical Officer, Executive VP and Head of Research & Development | 66 | |
| Mr. Stephen Marlow | Executive VP & GM of CSL Plasma | 53 | |
| Mr. Mark Hill B.A., M.B.A. | Chief Digital Information Officer & Executive VP | 63 | |
| Mr. Herve Gisserot | Executive VP of Business Development & Enterprise Alliance Management | 60 | |
| Ms. Kate Sophie Priestman | Chief Corporate & External Affairs Officer | 52 |
Profitability and management effectiveness
Profit margin
-16.33%
Operating margin
21.49%
Return on assets
7.26%
Return on equity
-15.83%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of CSL is 85.21B and its enterprise value is 95.93B. The enterprise value to revenue ratio of CSL is 6.07. The enterprise value to EBITDA ratio of CSL is 18.89.
The CSL's stocks Beta value is 0.13 making it 87% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to CSL (CSL)
CSL (ASX:CSL) Frequently Asked Questions
1. What is CSL's Stock Symbol?
CSL trades on ASX under the ticker symbol "CSL".
2. What is CSL's stock price today?
One share of CSL stock can currently be purchased for approximately $177.56.
3. How can I contact CSL?
CSL's mailing address is 655 Elizabeth Street Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 9389 1911.
4. What is CSL's official website?
The official website of CSL is https://www.csl.com.